Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS et al..
2018.
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.. JAMA Psychiatry. 75(1):84-95.
Illán-Gala I, Pegueroles J, Montal V, Vilaplana E, Carmona-Iragui M, Alcolea D, Dickerson BC, Sánchez-Valle R, de Leon MJ, Blesa R et al..
2018.
Challenges associated with biomarker-based classification systems for Alzheimer's disease.. Alzheimers Dement (Amst). 10:346-357.
Fortea J, Carmona-Iragui M, Benejam B, Fernández S, Videla L, Barroeta I, Alcolea D, Pegueroles J, Muñoz L, Belbin O et al..
2018.
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.. Lancet Neurol. 17(10):860-869.
Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleó A, Molinuevo JLuis, Jagust WJ et al..
2018.
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.. Alzheimers Dement. 14(7):913-924.